About AVXL

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.
Primary Exchange: NASDAQ
SIC Services-Commercial Physical & Biological Research
NAICS Pharmaceutical Preparation Manufacturing

AVXL is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.5 B 1.85179E+10 3,573 3573 0.0% 0 54 K 53596
IWC iShares Microcap ETF 909.3 M 9.09255E+08 1,452 1452 0.03% 0.0003 303 K 303331

Wait, Before You Leave...